References
- Furman S, Schwedel JB. An intracardiac pacemaker for Stokes–Adams seizures. N. Engl. J. Med.261, 943–948 (1959).
- Lim HS, Lip GY. Point of view: asymptomatic atrial fibrillation on device interrogation. J. Cardiovasc. Electrophysiol.19, 891–893 (2008).
- Rho RW, Page RL. Asymptomatic atrial fibrillation. Prog. Cardiovasc. Dis.48, 79–87 (2005).
- Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J. Am. Coll. Cardiol.51, 1–62 (2008).
- Wood MA. Automated pacemaker function. Cardiol. Clin.18, 177–191 (2000).
- Crossley GH, Chen J, Choucair W et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J. Am. Coll. Cardiol.54, 2012–2019 (2009).
- Schoenfeld MH. Transtelephonic versus remote monitoring of cardiovascular implantable electronic devices: is one approach to be preferred? J. Am. Coll. Cardiol.54, 2020–2022 (2009).
Website
- The data deluge and how to handle it. A 14-page special report in The Economist, issue of February 27th–March 5th 2010 www.economist.com/specialreports/displayStory.cfm?story_id=15557443